However, in human cancers retaining wild-type p53 gene, Mdm2 and MdmX proteins are often expressed at high levels, overcoming the growth-suppressive functions of p53 and contributing to tumor development (Momand et al., 1998; Toledo and Wahl, 2006). This evidence concerns the gene TP53 and cancer.